GlaxoSmithKline PLC Director/PDMR Shareholding

Data : 14/01/2020 @ 17:01
Fonte : UK Regulatory (RNS & others)
Titolo : Glaxosmithkline Plc (GSK)
Quotazione : 1661.6  0.0 (0.00%) @ 01:00
Quotazione Glaxosmithkline Grafico

GlaxoSmithKline PLC Director/PDMR Shareholding

Grafico Azioni Glaxosmithkline (LSE:GSK)
Storico

2 Mesi : Da Dic 2019 a Feb 2020

Clicca qui per i Grafici di Glaxosmithkline

TIDMGSK

RNS Number : 7922Z

GlaxoSmithKline PLC

14 January 2020

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms E Walmsley 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Executive Officer 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             1370.518 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr R Connor 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Vaccines 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             551.656 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms D Conrad 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Human Resources 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             6.696 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr J Ford 
====  ========================================  ==================================================== 
 b)    Position/status                          SVP & General Counsel 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ==================================================== 
 b)    Nature of the                            Acquisition of ADSs following the re-investment 
        transaction                              of dividends paid to shareholders on 9 
                                                 January 2020. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ========================= 
                                                 $47.0819                0.00127 
                                                 ======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ======================================================== 
 e)    Date of the transaction                  2020-01-10 
====  ========================================  ==================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr J Ford 
====  ======================================  ================================================= 
 b)    Position/status                        SVP & General Counsel 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             0.000024 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr N Hirons 
====  ========================================  ==================================================== 
 b)    Position/status                          SVP, Global Ethics & Compliance 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ==================================================== 
 b)    Nature of the                            Acquisition of ADSs following the re-investment 
        transaction                              of dividends paid to shareholders on 9 
                                                 January 2020. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ========================= 
                                                 $47.0819                17.000 
                                                 ======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ======================================================== 
 e)    Date of the transaction                  2020-01-10 
====  ========================================  ==================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr N Hirons 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Global Ethics & Compliance 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             319.264 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms S Jackson 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Global Communications and CEO Office 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             39.806 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================= 
 a)    Name                                   Mr D Jackson 
====  ======================================  ===================================================== 
 b)    Position/status                        PCA of Ms S Jackson (SVP, Global Communications 
                                               and CEO Office) 
====  ======================================  ===================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ===================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ===================================================== 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ===================================================== 
 c)    Price(s) and                            Price(s)                     Volume(s) 
        volume(s) 
====  ======================================   ===========================  ===================== 
   GBP18.0083                                                               42.882 
   =======================================================================  ===================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ====================================================================  ============================ 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ===================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr B McNamara 
====  ========================================  ==================================================== 
 b)    Position/status                          CEO, GSK Consumer Healthcare 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ==================================================== 
 b)    Nature of the                            Acquisition of ADSs following the re-investment 
        transaction                              of dividends paid to shareholders on 9 
                                                 January 2020. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ========================= 
                                                 $47.0819                681.093 
                                                 ======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ======================================================== 
 e)    Date of the transaction                  2020-01-10 
====  ========================================  ==================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr D Redfern 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Strategy Officer 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             2268.962 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr R Simard 
====  ======================================  ================================================= 
 b)    Position/status                        President, Pharmaceuticals Supply Chain 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             436.188 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr P Thomson 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Affairs 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             521.767 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms K Thomson 
====  ======================================  ================================================= 
 b)    Position/status                        PCA of Mr P Thomson (President, Global 
                                               Affairs) 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             113.744 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms D Waterhouse 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Executive Officer of ViiV Healthcare 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             65.603 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHEZLFFBFLEBBK

(END) Dow Jones Newswires

January 14, 2020 11:01 ET (16:01 GMT)

La tua Cronologia
BIT
BMPS
Monte Pasc..
BITI
FTSEMIB
FTSE Mib
BIT
UCG
Unicredit
NASDAQ
AAPL
Apple
FX
EURUSD
Euro vs Do..
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.

Registrati ora per creare la tua watchlist personalizzata in tempo reale streaming.

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V:it D:20200218 07:05:47